T1	Participants 108 145	patients with gastrointestinal cancer
T2	Participants 417 454	patients with gastrointestinal cancer
T3	Participants 747 817	512 patients with gastrointestinal cancer included in the TACTIC study
T4	Participants 1435 1472	patients with gastrointestinal cancer
